Yu Deng

Prof. Yu Deng

China Medical University

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
SYSeungwon Yang
Seungwon Yang
JWJiangbo Wei
Jiangbo Wei
YCYan-Hong Cui
Yan-Hong Cui
GPGayoung Park
Gayoung Park
PSPalak Shah
Palak Shah
YHYu-Ying He
Yu-Ying He
Melanoma is one of the most deadly and therapy-resistant cancers. Here we show that N6-methyladenosine (m6A) mRNA demethylation by fat mass and obesity-associated protein (FTO) increases melanoma growth and decreases response to anti-PD-1 blockade immunotherapy. FTO level is increased in human melanoma and enhances melanoma tumorigenesis in mice. FTO is induced by metabolic starvation stress through the autophagy and NF-κB pathway. Knockdown of FTO increases m6A methylation in the critical protumorigenic melanoma cell-intrinsic genes including PD-1 (PDCD1), CXCR4, and SOX10, leading to increased RNA decay through the m6A reader YTHDF2. Knockdown of FTO sensitizes melanoma cells to interferon gamma (IFNγ) and sensitizes melanoma to anti-PD-1 treatment in mice, depending on adaptive immunity. Our findings demonstrate a crucial role of FTO as an m6A demethylase in promoting melanoma tumorigenesis and anti-PD-1 resistance, and suggest that the combination of FTO inhibition with anti-PD-1 blockade may reduce the resistance to immunotherapy in melanoma.

20 August 2019 in Cell & Bioscience
Verified
Journal Article
Open access
PDF file
JLJiashuo Li
Jiashuo Li
XYXinxin Yang
Xinxin Yang
ZQZhipeng Qi
Zhipeng Qi
YSYanqi Sang
Yanqi Sang
YLYanan Liu
Yanan Liu
YDYu Deng
Yu Deng
Epitranscriptomics, also known as “RNA epigenetics”, is a chemical modification for RNA regulation. Ribonucleic acid (RNA) methylation is considered to be a major discovery following the deoxyribonucleic acid (DNA) and histone methylation. Messenger RNA (mRNA) methylation modification accounts for more than 60% of all RNA modifications and N6-methyladenosine (m6A) is known as one of the most common type of eukaryotic mRNA methylation modifications in current. The m6A modification is a dynamic reversible modification, which can directly or indirectly affect biological processes, such as RNA degradation, translation and splicing, and can play important biological roles in vivo. This article introduces the mRNA m6A methylation modification enzymes and binding proteins, and reviews the research progress and related mechanisms of the role of mRNA m6A methylation in the nervous system from the aspects of neural stem cells, learning and memory, brain development, axon growth and glioblastoma.


4 March 2020 in Cell & Bioscience
Verified
Journal Article
Open access
PDF file
XDXianchao Du
Xianchao Du
JLJiashuo Li
Jiashuo Li
MLMinghui Li
Minghui Li
XYXinxin Yang
Xinxin Yang
ZQZhipeng Qi
Zhipeng Qi
YDYu Deng
Yu Deng
Glutamate (Glu) is the predominant excitatory neurotransmitter in the central nervous system (CNS). Glutamatergic transmission is critical for controlling neuronal activity. In presynaptic neurons, Glu is stored in synaptic vesicles and released by stimulation. The homeostasis of glutamatergic system is maintained by a set of transporters in the membrane of synaptic vesicles. The family of vesicular Glu transporters in mammals is comprised of three highly homologous proteins: VGLUT1-3. Among them, VGLUT1 accounts for the largest proportion. However, most of the Glu is transported into the synaptic vesicles via the type 1 vesicle Glu transporter (VGLUT1). So, the expression of particular VGLUT1 is largely complementary with limited overlap and so far it is most specific markers for neurons that use Glu as neurotransmitter. Controlling the activity of VGLUT1 could potentially modulate the efficiency of excitatory neuro-transmission and change the filling level of synaptic vesicles. This review summarizes the recent knowledge concerning molecular and functional characteristic of VGLUT1, their development, contribution to a series of central nervous system and peripheral nervous system diseases such as learning and memory disorders, Alzheimer’s disease, Parkinson’s disease and sensitized nociception or pain pathology et al.

5 March 2021 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
LZLei Zhang
Lei Zhang
ZQZhipeng Qi
Zhipeng Qi
JLJiashuo Li
Jiashuo Li
MLMinghui Li
Minghui Li
XDXianchao Du
Xianchao Du
YDYu Deng
Yu Deng

29 March 2023 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
CWChen Wang
Chen Wang
HLHaihui Liu
Haihui Liu
SXSi Xu
Si Xu
YDYu Deng
Yu Deng
BXBin Xu
Bin Xu
WLWei Liu
Wei Liu